Tirzepatide Reconstitution & Syringe Unit Protocol

Vial strength, water volume, and the numbers that follow

Tirzepatide research vials are commonly supplied at 10 mg, 15 mg, 20 mg and 30 mg. The reconstitution decision is a single trade-off: less water means a smaller draw volume, more water means finer resolution on the syringe.

Worked examples

A 20 mg vial with 2 mL of bacteriostatic water yields 10 mg/mL. A 2.5 mg research dose is 0.25 mL, or 25 units on a U-100 syringe, giving 8 doses per vial.

The same 20 mg vial with 4 mL yields 5 mg/mL; the same 2.5 mg dose is now 50 units. The peptide mass drawn is identical — only the measurement resolution changed.

Titration-style protocols

Research protocols that step a dose across weeks benefit from a single concentration for the entire series, so the only variable that changes is the tick mark. Reconstituting each new vial to the same mg/mL keeps the series internally consistent.

Documentation

Every PX1 tirzepatide lot ships with an HPLC purity chromatogram and LC-MS identity confirmation. Verify the lot on the vial label against the published COA before use.

Common errors

• Assuming more water reduces total peptide — it does not.
• Reading a U-40 syringe as if it were U-100.
• Reconstituting the full catalog at once instead of as needed.
• Storing reconstituted material at room temperature.

For laboratory and research use only. Not for human or veterinary use.